CME Group Inc. (NASDAQ:CME) Stock Position Raised by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC lifted its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 32.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 52,167 shares of the financial services provider’s stock after purchasing an additional 12,653 shares during the period. Janney Montgomery Scott LLC’s holdings in CME Group were worth $11,231,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. B. Riley Wealth Advisors Inc. raised its holdings in CME Group by 1.3% during the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock worth $782,000 after buying an additional 48 shares during the period. Capital Advisors Ltd. LLC raised its holdings in shares of CME Group by 4.3% during the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after acquiring an additional 48 shares during the period. Lantz Financial LLC lifted its position in shares of CME Group by 1.1% in the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock valued at $982,000 after acquiring an additional 49 shares in the last quarter. Transcend Capital Advisors LLC boosted its stake in CME Group by 1.7% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock worth $631,000 after purchasing an additional 50 shares during the period. Finally, Greystone Financial Group LLC boosted its stake in CME Group by 1.6% in the 4th quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock worth $691,000 after purchasing an additional 52 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Price Performance

NASDAQ CME opened at $196.40 on Monday. The firm has a market cap of $70.72 billion, a P/E ratio of 22.34, a price-to-earnings-growth ratio of 5.18 and a beta of 0.52. The stock’s 50-day moving average is $203.55 and its two-hundred day moving average is $208.08. CME Group Inc. has a fifty-two week low of $180.11 and a fifty-two week high of $223.80. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.01.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.44 by $0.06. The business had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The firm’s revenue was up 3.2% compared to the same quarter last year. During the same period last year, the business earned $2.42 EPS. On average, analysts anticipate that CME Group Inc. will post 9.74 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Friday, June 7th were issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.34%. The ex-dividend date of this dividend was Friday, June 7th. CME Group’s dividend payout ratio is currently 52.33%.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Keefe, Bruyette & Woods reissued a “market perform” rating and set a $226.00 target price on shares of CME Group in a research note on Wednesday, July 3rd. JPMorgan Chase & Co. lowered CME Group from a “neutral” rating to an “underweight” rating and decreased their price objective for the stock from $206.00 to $187.00 in a research report on Friday, June 21st. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $210.00 target price (down previously from $235.00) on shares of CME Group in a research note on Friday, April 5th. Barclays increased their price target on shares of CME Group from $226.00 to $228.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 25th. Finally, Bank of America boosted their price objective on shares of CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a research report on Thursday, April 25th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, CME Group presently has an average rating of “Hold” and an average price target of $215.90.

Check Out Our Latest Stock Report on CME Group

Insider Buying and Selling

In related news, CEO Terrence A. Duffy sold 40,000 shares of CME Group stock in a transaction on Monday, April 29th. The shares were sold at an average price of $210.91, for a total value of $8,436,400.00. Following the transaction, the chief executive officer now owns 67,455 shares in the company, valued at approximately $14,226,934.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other CME Group news, CEO Terrence A. Duffy sold 40,000 shares of the firm’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $210.91, for a total value of $8,436,400.00. Following the sale, the chief executive officer now owns 67,455 shares of the company’s stock, valued at approximately $14,226,934.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the transaction, the director now owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The disclosure for this sale can be found here. In the last three months, insiders sold 54,290 shares of company stock valued at $11,393,700. Company insiders own 0.30% of the company’s stock.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.